Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 2
2013 1
2014 1
2015 8
2016 8
2017 7
2018 9
2019 11
2020 16
2021 21
2022 25
2023 19
2024 15
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Cognition in Multiple Sclerosis.
Cortese R, Carotenuto A, Di Filippo M, Lanzillo R. Cortese R, et al. Among authors: carotenuto a. Front Neurol. 2021 Aug 30;12:751687. doi: 10.3389/fneur.2021.751687. eCollection 2021. Front Neurol. 2021. PMID: 34526964 Free PMC article. No abstract available.
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis.
Spiezia AL, Pontillo G, Falco F, Eliano M, Lamagna F, Esposito A, Di Monaco C, Nicolella V, Novarella F, Moccia M, Cocozza S, Brunetti A, Lanzillo R, Petracca M, Brescia Morra V, Carotenuto A. Spiezia AL, et al. Among authors: carotenuto a. Eur J Neurol. 2025 May;32(5):e70009. doi: 10.1111/ene.70009. Eur J Neurol. 2025. PMID: 40312892 Free PMC article.
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis.
Novarella F, Nicolella V, Fiorenza M, Falco F, Monteiro I, Corsini G, Ranucci D, Carotenuto A, Petracca M, Lanzillo R, Salvatore E, Castaldo G, Brescia Morra V, Terracciano D, Moccia M. Novarella F, et al. Among authors: carotenuto a. J Neurol Sci. 2025 Aug 15;475:123562. doi: 10.1016/j.jns.2025.123562. Epub 2025 Jun 2. J Neurol Sci. 2025. PMID: 40482625 Free article.
Conventional MRI-Based Structural Disconnection and Morphometric Similarity Networks and Their Clinical Correlates in Multiple Sclerosis.
Tranfa M, Petracca M, Moccia M, Scaravilli A, Barkhof F, Brescia Morra V, Carotenuto A, Collorone S, Elefante A, Falco F, Lanzillo R, Lorenzini L, Schoonheim MM, Toosy AT, Brunetti A, Cocozza S, Quarantelli M, Pontillo G. Tranfa M, et al. Among authors: carotenuto a. Neurology. 2025 Feb 25;104(4):e213349. doi: 10.1212/WNL.0000000000213349. Epub 2025 Jan 23. Neurology. 2025. PMID: 39847748 Free PMC article.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group. Signoriello E, et al. Among authors: carotenuto a. Mult Scler Relat Disord. 2024 Jul;87:105594. doi: 10.1016/j.msard.2024.105594. Epub 2024 Apr 6. Mult Scler Relat Disord. 2024. PMID: 38718748 Free article.
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod.
Carotenuto A, Di Monaco C, Papetti L, Borriello G, Signoriello E, Masciulli C, Tomassini V, De Luca G, Ianniello A, Lus G, Novarella F, Spiezia AL, Di Somma D, Moccia M, Petracca M, Iacovazzo C, Servillo G, Portaccio E, Triassi M, Amato MP, Pozzilli C, Valeriani M, Brescia Morra V, Lanzillo R. Carotenuto A, et al. J Neurol. 2024 Oct;271(10):6773-6781. doi: 10.1007/s00415-024-12610-y. Epub 2024 Aug 23. J Neurol. 2024. PMID: 39177751 Free PMC article.
Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis.
Nicolella V, Fiorenza M, Monteiro I, Novarella F, Sirica R, D'Angelo M, Carbone G, La Civita E, Esposito A, Criscuolo V, Carotenuto A, Petracca M, Lanzillo R, Castaldo G, Morra VB, Terracciano D, Moccia M. Nicolella V, et al. Among authors: carotenuto a. J Neurol Sci. 2024 Aug 15;463:123115. doi: 10.1016/j.jns.2024.123115. Epub 2024 Jun 27. J Neurol Sci. 2024. PMID: 38964268 Free article.
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.
Barbuti E, Castiello A, Pozzilli V, Carotenuto A, Tomasso I, Moccia M, Ruggieri S, Borriello G, Lanzillo R, Morra VB, Pozzilli C, Petracca M. Barbuti E, et al. Among authors: carotenuto a. Neurotherapeutics. 2025 Mar;22(2):e00537. doi: 10.1016/j.neurot.2025.e00537. Epub 2025 Jan 28. Neurotherapeutics. 2025. PMID: 39880749 Free PMC article.
134 results